EQS-News: aap Implantate AG / Key word(s): Capital Increase aap successfully places a 10% capital increase from authorized capital at EUR 1.10 with exclusion of subscription rights 19.04.2024 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. The premium to the current share price of EUR 0.8 amounted to 37.5% The cash inflow will strengthen the company's own resources for the ongoing human clinical trial of the innovative antibacterial implant technology aap Implantate AG ("aap" or "Company") successfully completed the 10% capital ...
EQS-News: aap Implantate AG / Schlagwort(e): Kapitalerhöhung aap platziert zu EUR 1,10 erfolgreich eine 10% Kapitalerhöhung aus genehmigtem Kapital unter Ausschluss des Bezugsrechts 19.04.2024 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Die Prämie zum aktuellen Aktienkurs von EUR 0,8 betrug 37.5% Der Liquiditätszufluss wird die Eigenleistungen für die laufende klinische Humanstudie der innovativen antibakteriellen Implantat-Technologie stärken Die aap Implantate AG („aap“ oder „Gesellschaft“) konnte erfolgreich die am ...
A director at Traumhaus AG sold 3,450,000 shares at 0.120EUR and the significance rating of the trade was 81/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...
A director at MM Group Industrial & International Trade (In Kind) bought 1,000,000 shares at 0.000EGP and the significance rating of the trade was 66/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's d...
Transaction in Own Shares ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES London, 19 April 2024 – Endeavour Mining plc (LSE:EDV, TSX:EDV) (“the Company”) announces it has purchased the following number of its ordinary shares of USD 0.01 each from Stifel Nicolaus Europe Limited. Aggregated information Dates of purchase:18 April 2024Aggregate number of ordinary shares of USD 0.01 each purchased:4,000Lowest price paid per share (GBp): 1,717.00Highest price paid per share (GBp): 1,722.00Volume weighted average price paid per share (GBp): 1,719.00 Following the cance...
BGHL (EUR): NAV(s) BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company. Close of business 18 Apr 2024. Estimated NAV Euro SharesSterling SharesEstimated NAV€ 27.8879£ 24.9691Estimated MTD return 1.22 % 1.30 %Estimated YTD return 1.23 % 1.62 %Estimated ITD return 178.88 % 149.69 % NAV and returns are calculated net of management and performance fees Market information Euro SharesAmsterdam (AEX)London (LSE)...
BGHL (GBP): NAV(s) BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company. Close of business 18 Apr 2024. Estimated NAV Euro SharesSterling SharesEstimated NAV€ 27.8879£ 24.9691Estimated MTD return 1.22 % 1.30 %Estimated YTD return 1.23 % 1.62 %Estimated ITD return 178.88 % 149.69 % NAV and returns are calculated net of management and performance fees Market information Euro SharesAmsterdam (AEX)London (LSE)...
ARGAN: Mr. Aymar de GERMAY is appointed at the Executive Board of ARGAN Press release – Neuilly-sur-Seine, Friday, April 19, 2024 – 7.30 am Mr. Aymar de GERMAY is appointed at the Executive Board of ARGAN Upon proposal of the Nominations and Remuneration Committee, the Supervisory Board of Argan decided, on April 18, 2024, to appoint Mr. Aymar de GERMAY as a member of the Executive Board replacing Mr. Frédéric LARROUMETS, who resigned, with immediate effect and for the remaining duration of the term. Aged 50, Mr. Aymar de GERMAY joined the Company in July 2022. A graduate of S...
ARGAN : Monsieur Aymar de GERMAY intègre le Directoire d’ARGAN Communiqué de presse – Neuilly-sur-Seine, Vendredi 19 avril 2024 – 7h30 Monsieur Aymar de GERMAY intègre le Directoire d’ARGAN Sur proposition du Comité des Nominations et Rémunérations, le Conseil de Surveillance d’ARGAN, réuni le 18 avril 2024, a décidé de nommer Monsieur Aymar de GERMAY en qualité de membre du Directoire à compter de ce jour en remplacement de Monsieur Frédéric LARROUMETS, démissionnaire et pour la durée restante de son mandat. Âgé de 50 ans, Aymar de GERMAY a rejoint la Foncière en juillet 2022. ...
A director at Washington H. Soul Pattinson & Company Limited bought 15,034 shares at 33.310AUD and the significance rating of the trade was 87/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's director...
Two Directors at Aboitiz Equity Ventures Inc bought 1,896,400 shares at between 38.974PHP and 39.438PHP. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's di...
A director at Global Top E-Commerce Co Ltd sold 1,756,700 shares at 2.240CNY and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...
A director at Shinhan Financial Group Co Ltd bought 500 shares at 40,550.000KRW and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...
Sodexo - Financial report for First half Fiscal 2024 available Regulated information Issy-les-Moulineaux, April 19, 2024 Financial Report for First half Fiscal 2024 available Sodexo announces that its First half Fiscal 2024 Financial report is available online and filed with the Autorité des marchés financiers (AMF). This document is available on Sodexo’s website, , under “Regulated information” in the ”Investors section”. It includes the condensed consolidated financial statements for First half Fiscal 2024, the First half activity report, the statement of responsibility for the First ...
Biophytis / Key word(s): Miscellaneous Biophytis announces ratio change under its American Depositary Receipt (“ADR”) program 19-Apr-2024 / 07:00 CET/CEST Biophytis announces ratio change under its American Depositary Receipt (“ADR”) program Paris (France) and Cambridge (Massachusetts, USA), April 19, 2024 – 07:00am CET – Biophytis SA (Nasdaq CM : BPTS, Euronext Growth Paris : ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics for age-related diseases, today annouces that it will change the ratio o...
Biophytis / Mot-clé(s) : Autres Biophytis annonce un changement de ratio pour son programme d'American Depositary Receipt ('ADR') 19-Avr-2024 / 07:00 CET/CEST Biophytis annonce un changement de ratio pour son programme d'American Depositary Receipt ("ADR") Paris, France, Cambridge (Massachusetts, États-Unis), 19 avril 2024 – 7h00 – Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS), («Biophytis» ou la «Société»), une société de biotechnologie au stade clinique spécialisée dans le développement de traitements pour les maladies liées à l'âge, annonce aujourd'hui qu'elle...
Cicor Technologies Ltd / Key word(s): AGMEGM Cicor Technologies Ltd. – Shareholders approve all proposals 19.04.2024 / 07:00 CET/CEST Bronschhofen, April 19, 2024 – At yesterday's Annual General Meeting of Cicor Technologies Ltd. (SIX Swiss Exchange: CICN) in Zurich, the shareholders approved all proposals. The Annual General Meeting approved the 2023 annual report, the annual financial statements, the consolidated financial statements, the sustainability report and the appropriation of available earnings. It also granted discharge to the members of the Board of Directors and Group...
Cicor Technologies Ltd / Schlagwort(e): Generalversammlung Cicor Technologies Ltd. – Aktionärinnen und Aktionäre genehmigen alle Anträge 19.04.2024 / 07:00 CET/CEST Bronschhofen, 19. April 2024 – An der gestrigen ordentlichen Generalversammlung der Cicor Technologies Ltd. (SIX Swiss Exchange: CICN) in Zürich haben die Aktionärinnen und Aktionäre allen Anträgen zugestimmt. Die Generalversammlung genehmigte den Jahresbericht 2023, die Jahresrechnung, die Konzernrechnung, den Nachhaltigkeitsbericht sowie die Verwendung des Bilanzergebnisses und erteilte den Mitgliedern des Verwaltungs...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.